AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS
NCT ID: NCT05710796
Last Updated: 2023-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2021-09-01
2022-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Surveillance Based on Smart Wearable Device
NCT04459637
Cardiovascular Assessment in Patient Recovered From COVID-19 and Recovery of Autonomic Nervous System in Association With the Severity of the Disease
NCT05081362
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
NCT05063812
Telemedicine in Outpatient Covid-19 Patients
NCT04471636
The Long COVID-19 Wearable Device Study
NCT05741112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives of the study:
1. To study causes and risk factors of cardiac disorders associated with COVID-19
2. To identify different types of cardiac symptoms patients, present with
3. To study the impact of co-morbidities on COVID-19 recovered patients
4. To study treatment patterns and duration of therapy
Plan to study:
* To select the patient based on inclusion and exclusion criteria
* To collect the patient information from case sheets and by patient interaction
* To identify different types of cardiac disorders related to COVID-19 or its treatment regimen
* To study the management of COVID-19 complication and related cardiovascular disorders
Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months
Subject Eligibility:
1. Inclusion Criteria
* Patients who are willing to participate
* Patients having previous COVID-19 treatment record
* Prescriptions reported during the study period
* The prescription which is legible and complete
2. Exclusion Criteria
* Patients who are not willing to participate
* The patient having no history of COVID-19 and available data
Source of the data:
1. Review of patient case sheet, prescription and lab reports
2. Personal interaction with patients and caregivers
Sample size: 500 Patients
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All population
The total population reported to Cardiology department during enrollment period
Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease
COVID recovered
Patient having history of COVID 19 disease
Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease
No history of COVID
Population those who never exposed to COVID 19 disease and never suffers
Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having previous COVID-19 treatment record
* Prescriptions reported during the study period
* The prescription which is legible and complete
Exclusion Criteria
* The patient having no history of COVID-19 and available data
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kakatiya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Satyam Suman
Department of Pharmacy Practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Srinivasa Heart Centre
Warangal, Telangana, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IECHS/CCP/DOPP/09/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.